Accepted Abstracts

  • Abyzov, Alexej (#55) Spectrum of somatic variations in healthy skin fibroblasts
  • Allen, Jacob (#97) Voluntary, but not forced, exercise alters the microbiome in the feces and cecum of C57Bl/6J mice
  • Baheti, Saurabh (#82) Role of adipose tissue methylome changes in unraveling pathophysiology of new-onset diabetes after kidney transplantation
  • Bani Asadi, Narges (#81) Democratizing genetic analysis and the future of personalized medicine
  • Beek, Geoffrey (#102) Recurrent ependymoma in a patient with BAP1 and RET gene germline mutations
  • Bhagwate, Aditya Vijay (#48) Next-generation sequencing on RNA captured fresh and formalin fixed paraffin-embedded samples
  • Biernacka, Joanna (#63) Interaction between TCF7L2 and NPY SNPs may contribute to bipolar disorder susceptibility
  • Black, John Logan (#6) Pharmacogenomics gene panel at Mayo Clinic
  • Blackburn, Patrick (#20) Utilizing TALENs and transposons for individualized medicine: Modeling a private mutation in a family with early-onset cirrhosis and hepatocellular carcinoma
  • Boughey, Judy (#38) Gene expression analysis in triple-negative breast cancers following neoadjuvant chemotherapy
  • Caraballo, Pedro (#45) Clinical decision support driving pharmacogenomics education
  • Caselli, Richard (#2) Predictive testing for Alzheimer's disease: Suicidal ideation among healthy participants
  • Cen, Ling (#68) Identification of recurrent protein-tyrosine-phosphatase chromosomal rearrangements in aggressive prostate cancer
  • Chen, Richard (#100) 10 common misconceptions of clinical NGS sequencing
  • Chen, Xianfeng (#23) Illinois-Mayo Taxon Organization from RNA Dataset Operations pipeline for 16S rDNA microbiome analysis
  • Chitoor, Shweta (#36) Quantitative fluorescence in situ hybridization in FFPE tumor tissue using monovalent quantum dot-click-DNA conjugates
  • Clift, Kristin (#73) The diagnostic crusade: How patients and families are advancing individualized medicine
  • Cousin, Margot (#65) Individualizing the treatment of tobacco dependence by assessing behavioral endophenotypes and molecular adaptations in zebrafish
  • Davila, Jaime (#44) Tananger: A tool for reference-based reconstruction of full transcripts from long sequencing reads
  • Dougherty, Gregory (#87) BioR Web: A Web interface for annotating VCF files
  • Elkin, Sheryl (#56) The scope of NGS testing: A study of ERBB2 and BRAF
  • Evans, Jared (#90) miRNA expression changes in patients with end-stage kidney disease who develop new-onset diabetes after transplant
  • Fadra, Numrah (#52) Copy number deletion detection of exons in pheocytochromas using next-generation sequencing of long-range polymerase chain reaction (PCR) products
  • Fakhrai-Rad, Hossein (#61) Changing patient behavior through comprehensive risk analysis with genomic and health data
  • Fiksdal, Alex (#86) A proof-of-principle pharmacogenomic study: Individuals' motivations for participating
  • Fisch, Kathleen (#26) An integrative framework for personalized genomic medicine
  • Flotte, Thomas (#9) Balancing the need to preserve patient tissues for future testing with the need for patient biopsies in research
  • Formea, Christine (#83) Strategies for developing a pharmacogenomics education program for pharmacists on a multicampus health care system
  • Freimuth, Robert (#95) Evaluating the application of star allele nomenclature for pharmacogenomics in the era of high-throughput sequencing
  • Frye, Mark (#53) Mitochondrial DNA sequence analysis of patients with bipolar disorder
  • Greenwood Quaintance, Kerryl (#22) A metagenomic approach for the detection of bacteria from sonicate fluids
  • Halverson, Colin (#69) Was it worth it? Patients' perspectives on the value of individualized medicine
  • Harris, Faye (#67) The liquid biopsy: Detection of somatic chromosomal rearrangements in circulating cell-free DNA of cancer patients
  • Hart, Steven (#1) VCF-Miner: A GUI-based tool for querying and filtering VCF files
  • Hassan, Umer (#12) Immuno-capture assay to electrically enumerate specific leukocytes in a microfluidic biochip
  • Hilker, Christopher (#51) Large fragment DNA library preparation: The bioinformatic advantages and significance
  • Hou, Jack (#47) DawnRank: Discovering personalized driver genes in cancer
  • Jang, Jin (#14) Genomic profiling by mRNA-seq in single cells
  • Jeraldo, Patricio (#11) Deep metagenomic sequencing for de novo assembly of genomes from the gut microbiota
  • Kalari, Krishna (#37) LCLbio: A computational platform to obtain genomics and pharmacologic associations from lymphoblastoid cell lines
  • Kang, Barinder (#103) The Signature Program: A series of tissue-agnostic, genetic-aberration-specific signal-finding trials
  • Karpyak, Victor (#54) Gender-specific association of prodynorphin sequence variation with alcohol dependence
  • Kashiwagi, Katsunobu (#85) Differential role of the ten-eleven translocation (TET) proteins in heterochromatin formation
  • Khai Pang, Leong (#93) An evaluation of association between two PTPN22 promoter SNPs and rheumatoid arthritis
  • Kohli, Manish (#92) Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE): A Mayo Clinic and Mayo Health Systems (MHS) study of pharmacogenetic markers associated with primary resistance to abiraterone acetate/prednisone (AA/P) in metastatic castration-resistant prostate cancer
  • Komandur Elayavilli, Ravikumar (#76) Text mining for pathway curation empowers pharmacogenomics
  • Kortum, K. Martin (#28) The updated Multiple Myeloma Mutation Panel (M3P): A practical tool to identify mutations in 77 critical genes in multiple myeloma by real-time targeted sequencing
  • Kostko, Aaron (#4) Closing the regulatory gap between pharmacogenomic research and the Orphan Drug Act
  • Kurmi, Kiran (#57) Creatine metabolism in HER2+ breast cancer
  • Kurtin, Paul (#78) Amyloid proteomics individualizes therapy: Mayo Clinic experience in 4,139 cases
  • Lagerstedt, Susan (#18) An Excel bioinformatics tool for the old generation
  • Larson, Nicholas (#99) Bayesian inference of tumor evolution
  • Li, Xing (#42) Disease-related genes and pathways via integrating patient-specific iPSC-derived RNA-seq and whole-genome sequencing in hypoplastic left heart syndrome
  • Liu, Hongfang (#74) Facilitating decision-making in individualized medicine through advanced text mining
  • Long, Pamela (#16) Whole-exome sequencing establishes diagnosis of Alstrom syndrome in an infant presenting with nonsyndromic dilated cardiomyopathy
  • Mangalam, Ashutosh (#21) Pro-inflammatory gut microbiota: An important pathogenic factor in immunopathogenesis of multiple sclerosis
  • McAllister, Tammy (#24) Establishing predictive genomic clinical services for the otherwise healthy adult patient at a large academic institution
  • McDonough, Samantha Jo (#8) A comparison of whole-genome amplification techniques for single cell amplification and target enrichment
  • Mcree, Chad Warren (#64) Novel treatment approaches to elevated Lp(a) lipoprotein and severe hypercholesterolemia
  • Meissner, Tobias (#3) OncoRep: An n-of-1 reporting tool to support genome-guided treatment for breast cancer patients using RNA-sequencing
  • Meyer, Jeff (#17) A sample ID validation assay for detection of processing errors in a molecular genomics core
  • Nadauld, Lincoln (#35) Intermountain cancer genomics: Implementation of clinical cancer genomics within an integrated health care system
  • Nair, Asha (#60) CircRNAdb: A catalog of circular RNAs
  • Nandakumar, Kannabiran (#70) Benchmarking a pipeline for analysis of sequencing data from families
  • Nelson, Justin (#89) Large-scale chemical genetic interaction mapping pipeline for mode-of-action characterization of complete compound collections
  • Nelson, Michael (#72) Comparing new generation -80ยบ C freezers to existing models for efficient and effective biorepository storage
  • Newburn, Erin (#98) The ACE Clinical Exome test: Combining a clinical-grade exome, advanced reference, and enhanced interpretation engine for enhancing diagnostic yield in genetic syndromes and cancer discovery
  • O'Brien, Daniel (#77) Characterization of interspersed copy number variants (iCNVs) in short-read sequencing experiments
  • Oliver, Gavin (#31) RNA-seq analysis augments clinical DNA testing in an individualized oncology setting
  • Olson, Janet (#39) Comparison of patient self-report and EMR-derived phenotype algorithms in the Mayo Clinic Biobank
  • Priya, Sambhawa (#80) A Semantic Web-based system for mining contextual knowledge of the druggable genome in cancer clinical trials
  • Prodduturi, Naresh (#88) Single sample genotype imputation using EZimputer improves variant calling from next-generation sequencing
  • Rakhshan, Fariborz (#15) Strand-specific RNA-seq for highly degraded samples
  • Resch, Zachary (#10) The Center for Regenerative Medicine Biotrust: Providing services to facilitate the translation of regenerative therapies at Mayo Clinic
  • Ryu, Euijung (#43) TCF7L2 polymorphisms influence lithium response among patients with bipolar disorder
  • Sarangi, Vivekananda (#19) A back-fill pipeline for identification of sub-clonal mutations in tumor DNA sequencing data
  • Schaefer-Klein, Janet (#29) TOP2A in prostate cancer progression and treatment sensitivity
  • Schahl, Kimberly (#75) Identification of actionable germline mutations in women newly diagnosed with high-risk breast cancer enrolled in the Breast Cancer Genome Guided Therapy Study (BEAUTY)
  • Simpkins, Scott (#71) Chemical-centric drug discovery using ultrahigh-throughput yeast chemical genomics
  • Sohn, Sunghwan (#79) MedXN: Medication extraction and normalization tool for clinical text
  • Sottara, Davide (#96) Developing shareable CDS rules based on pharmacogenomics guidelines using the Health eDecisions interoperability standard
  • Sun, Zhifu (#91) Statistical models in differentially methylated CpG detection for bisulfite sequencing data: The simple beats the complex
  • Takahashi, Paul (#5) A genome-wide association study identifies CNTNAP2 as a potential susceptibility locus for hospitalization
  • Tang, Xiaojia (#41) Investigation of human endogenous retrovirus in breast tumors
  • Tavartkiladze, Alexandre (#101) Influence of agomelatine and trastuzumab on the HER2/neu(+), MT1 (+) and MT2 (+) chemo and immunoresistant breast cancer cell lines from the previously treated patients by chemotherapy with trastuzumab
  • Theis, Jeanne (#13) Exome sequencing reveals candidate genes for spontaneous coronary artery dissection
  • Thompson, Kevin (#50) miRNA regulation of the blood brain barrier through intracellular paracrine signaling
  • Tiedemann, Rochelle (#58) Acute depletion reveals novel divisions of labor among the DNA methyltransferases in cancer
  • Tu, Zheng Jin (#49) Bioinformatics studies for variant detection for genes that have pseudogene or share high homology with other regions
  • Ung, Ryan (#66) Fabry disease: A look forward at enzyme replacement
  • Vanderboom, Patrick (#59) Individualized monitoring of patients with monoclonal gammopathy: Optimizing sample preparation for mass spectrometry
  • Vedell, Peter (#94) Bioinformatics analysis and consideration of structural variants in targeted sequencing of formalin-fixed, paraffin-embedded (FFPE) DNA samples
  • Walker, Denise (#33) Assay development for BRAF V600E detection in cell-free DNA (cfDNA) using digital droplet PCR
  • Walther-Antonio, Marina (#7) Porphyromonas sp. presence in the uterus as an indicator of endometrial cancer
  • Wang, Che (#30) PatternCNV: A versatile tool for detecting germline and somatic copy number variants from exome sequencing data
  • Wick, Myra (#27) Mayo Clinic umbilical cord and placental tissues repository: 2014 update
  • Winham, Stacey (#46) Replication of interaction between TCF7L2 variants and body mass index on risk for bipolar disorder
  • Winkler, Erin (#25) Role of a genetic counselor in the return of research results to biobank participants
  • Yadav, Pranjul (#84) Progression and risk assessment of comorbid conditions in type 2 diabetes mellitus
  • Yan, Huihuang (#40) ChIP-seq reveals alteration of H3K36me3 occupancy in renal cell carcinoma
  • Yu, Jia (#32) Evaluation of taxane response in established xenograft derived from breast cancer patients
  • Zahid, Mohammad (#34) Imaging cell-to-cell signals that mediate tumor metastasis at the single-molecule level
  • Zimmermann, Michael (#62) A strategy for leveraging personal genomics in determining the effectiveness of targeted therapies for individual cancer patients

Poster Guidelines

Each author is contacted with additional details before the conference. Please email imconference@mayo.edu if you have questions or need more information about the poster session or guidelines.

  • The poster session is scheduled for Tuesday, Oct. 7, from 5-7 p.m.
  • Put up your poster by end of day on Monday, Oct. 6.
  • Posters must fit within a space that is 8 feet wide and 4 feet high. Do not exceed these dimensions.
  • Use Velcro to secure posters to display board, not pushpins or tacks.
  • Poster space is assigned; a space number is provided to each author.
  • Posters must be taken down by 10:30 a.m. on Wednesday, Oct. 8.

Newsletter Icon Sign up for updates